Company registration number 09430463 (England and Wales)
THE GARDEN NURSERY (LONDON) LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024
THE GARDEN NURSERY (LONDON) LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 9
THE GARDEN NURSERY (LONDON) LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2024
31 October 2024
- 1 -
2024
2023
Notes
£
£
FIXED ASSETS
Intangible assets
3
2,000
4,000
Tangible assets
4
18,543
28,940
Investment property
5
257,175
-
0
277,718
32,940
CURRENT ASSETS
Debtors
6
262,963
241,917
Cash at bank and in hand
893,056
1,020,691
1,156,019
1,262,608
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
7
(242,947)
(267,918)
NET CURRENT ASSETS
913,072
994,690
TOTAL ASSETS LESS CURRENT LIABILITIES
1,190,790
1,027,630
CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
8
-
(416)
NET ASSETS
1,190,790
1,027,214
CAPITAL AND RESERVES
Called up share capital
100
100
Profit and loss reserves
1,190,690
1,027,114
TOTAL EQUITY
1,190,790
1,027,214
THE GARDEN NURSERY (LONDON) LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 OCTOBER 2024
31 October 2024
- 2 -

For the financial year ended 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 29 September 2025 and are signed on its behalf by:
Mr L Spear
Director
Company registration number 09430463 (England and Wales)
THE GARDEN NURSERY (LONDON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024
- 3 -
1
ACCOUNTING POLICIES
Company information

The company is a private company limited by shares, registered in England and Wales. The address of the principal place of business is 131 East Acton Lane, London W3 7HB.

1.1
Accounting convention

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

The financial statements are prepared in sterling, which is the functional currency of the entity.

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

1.2
Turnover

The turnover shown in the profit and loss account is derived from ordinary activities and represents the value of nursery fees receivable in the financial year.

1.3
Goodwill

Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business.

 

Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.

1.4
Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

Goodwill
10% on cost

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

THE GARDEN NURSERY (LONDON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2024
1
ACCOUNTING POLICIES
(Continued)
- 4 -
1.5
Tangible fixed assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

 

An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

1.6
Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Property improvements
2% on cost
Fixtures and fittings
15% on cost
1.7
Investment property

Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss.

1.8
Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.

For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

THE GARDEN NURSERY (LONDON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2024
1
ACCOUNTING POLICIES
(Continued)
- 5 -
1.9
Financial instruments

A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Debt instruments are subsequently measured at amortised cost.

Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment.

Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.

For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.

Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

1.10
Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively.

Current tax

Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

THE GARDEN NURSERY (LONDON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2024
1
ACCOUNTING POLICIES
(Continued)
- 6 -
Deferred tax

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

1.11
Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund.

When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

1.12
Operating leases

Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.

1.13

Finance leases and hire purchase contracts

Assets held under finance leases and hire purchase contracts are recognised in the balance sheet as assets and liabilities at the lower of the fair value of the assets and the present value of the minimum lease payments, which is determined at the inception of the lease term. Any initial direct costs of the lease are added to the amount recognised as an asset.

Lease payments are apportioned between the finance charges and reduction of the outstanding lease liability using the effective interest method. Finance charges are allocated to each period so as to produce a constant rate of interest on the remaining balance of the liability.

2
EMPLOYEES

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
55
53
THE GARDEN NURSERY (LONDON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2024
- 7 -
3
INTANGIBLE FIXED ASSETS
Goodwill
£
Cost
At 1 November 2023 and 31 October 2024
20,000
Amortisation and impairment
At 1 November 2023
16,000
Amortisation charged for the year
2,000
At 31 October 2024
18,000
Carrying amount
At 31 October 2024
2,000
At 31 October 2023
4,000
4
TANGIBLE FIXED ASSETS
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 November 2023 and 31 October 2024
10,736
188,214
198,950
Depreciation and impairment
At 1 November 2023
520
169,490
170,010
Depreciation charged in the year
215
10,182
10,397
At 31 October 2024
735
179,672
180,407
Carrying amount
At 31 October 2024
10,001
8,542
18,543
At 31 October 2023
10,216
18,724
28,940
THE GARDEN NURSERY (LONDON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2024
- 8 -
5
INVESTMENT PROPERTY
2024
£
Fair value
At 1 November 2023
-
0
Additions
257,175
At 31 October 2024
257,175

The directors have valued the investment property on the basis of open market value and they believe this is not materially different from cost.

 

6
DEBTORS
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
62,563
73,456
Other debtors
200,400
168,461
262,963
241,917
7
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024
2023
£
£
Bank loans
416
1,665
Corporation tax
130,480
179,502
Other taxation and social security
30,610
13,473
Other creditors
81,441
73,278
242,947
267,918
8
CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024
2023
£
£
Bank loans and overdrafts
-
0
416
THE GARDEN NURSERY (LONDON) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2024
- 9 -
9
DIRECTORS' TRANSACTIONS

Included within other debtors is £369,981 (2023 - £151,611) due from directors.

 

The balances are interest free and repayable on demand.

 

In relation to the overdrawn balances,the following transactions took place during the year;

Description
% Rate
Opening balance
Amounts advanced
Amounts repaid
Closing balance
£
£
£
£
Director 1
-
95,066
113,540
(4,326)
204,280
Director 2
-
56,545
113,051
(3,896)
165,700
151,611
226,591
(8,222)
369,980
2024-10-312023-11-01falsefalsefalse29 September 2025CCH SoftwareCCH Accounts Production 2025.200The principal activity of the company is that of child day care activities.
Miss S BautistaMs R Soto MarinMr T C H KilsbyMr L Spear
094304632023-11-012024-10-31094304632024-10-31094304632023-10-3109430463core:NetGoodwill2024-10-3109430463core:NetGoodwill2023-10-3109430463core:LandBuildings2024-10-3109430463core:OtherPropertyPlantEquipment2024-10-3109430463core:LandBuildings2023-10-3109430463core:OtherPropertyPlantEquipment2023-10-3109430463core:CurrentFinancialInstrumentscore:WithinOneYear2024-10-3109430463core:CurrentFinancialInstrumentscore:WithinOneYear2023-10-3109430463core:ShareCapital2024-10-3109430463core:ShareCapital2023-10-3109430463core:RetainedEarningsAccumulatedLosses2024-10-3109430463core:RetainedEarningsAccumulatedLosses2023-10-3109430463bus:Director42023-11-012024-10-3109430463core:Goodwill2023-11-012024-10-3109430463core:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-3109430463core:ComputerSoftware2023-11-012024-10-3109430463core:LandBuildingscore:OwnedOrFreeholdAssets2023-11-012024-10-3109430463core:FurnitureFittings2023-11-012024-10-31094304632022-11-012023-10-3109430463core:NetGoodwill2023-10-3109430463core:NetGoodwill2023-11-012024-10-3109430463core:LandBuildings2023-10-3109430463core:OtherPropertyPlantEquipment2023-10-31094304632023-10-3109430463core:LandBuildings2023-11-012024-10-3109430463core:OtherPropertyPlantEquipment2023-11-012024-10-3109430463core:CurrentFinancialInstruments2024-10-3109430463core:CurrentFinancialInstruments2023-10-3109430463core:WithinOneYear2024-10-3109430463core:WithinOneYear2023-10-3109430463core:Non-currentFinancialInstruments2024-10-3109430463core:Non-currentFinancialInstruments2023-10-3109430463bus:PrivateLimitedCompanyLtd2023-11-012024-10-3109430463bus:SmallCompaniesRegimeForAccounts2023-11-012024-10-3109430463bus:FRS1022023-11-012024-10-3109430463bus:AuditExemptWithAccountantsReport2023-11-012024-10-3109430463bus:Director12023-11-012024-10-3109430463bus:Director22023-11-012024-10-3109430463bus:Director32023-11-012024-10-3109430463bus:FullAccounts2023-11-012024-10-31xbrli:purexbrli:sharesiso4217:GBP